MITF and breast carcinoma: Encouraged by MITF’s prognostic value in basal breast cancer patients, we directly examined the functional impact of loss of MITF in basal breast cancer cells by transducing MDA-MB-436 cells with inducible MITF shRNAs followed by RNA-seq.